Abstract:This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editors. The substance of the retraction is as follows: Attention has been drawn by Dr Elisabeth Bik to the fact that similar images representing the results of different experiments are shown in Figures 1G and 3F. She also points to the remarkable similarity between the legend text and line graphs of Figure 1 of the Biochimie article, Jia et al (2019), and Figure 1 of a publication in Eur Rev Med Pharmacol Sci (2019), Xu et al (2019). The latter article has since been retracted. An anomymous reader has observed that Figures 1G and 3F show three rows of images shared with Figure 4 of the first-published version of a manuscript in the Journal of the Balkan Union of Oncology (J BUON), Tan et al (2019), submitted and accepted for publication before the submission of the Biochimie article, though it has since publication undergone unexplained modification to Figure 4. Furthermore, the panels shared between the Biochimie and J BUON articles are similar to panels in Figure 7 of a much earlier manuscript, published in October 2017 in Science Reports (Dai et al), as well as to a figure in a later article, Li et al (2020). In addition, the top panel of Figure 3G in Jia et al (2019) as well as the two lower panels is also similar to a part of Figure 7, Dia et al (2017). Further unexplained anomalies concern Figure 3C of Jia et al (2019). The editors would like to thank Dr Bik and the anonymous reader for their valuable insight in this matter. The above observations cast serious doubt on the scientific integrity of the Biochimie article. Confronted with the observation that panels in Figures 1G and 3F were similar though representing different experiments, the authors replied to the editors that the bottom panel in Figure 3F was a mistake and would be corrected. They were not able to produce the raw data when requested, and proposed to the editors to repeat the experiments. However, no new data have been received by the editors at the time of writing, and would not change the serious doubts that they harbour concerning the integrity of the work published in Biochimie. Therefore, the editorial team has opted for retraction irrespective of any new results. This decision has been accepted by the authors.

Changed Expression of Micrornas May Predict Postoperative Atrial Fibrillation in Patients with Cardiac Surgery.

Circ0021205 Aggravates the Progression of Non-Small Cell Lung Cancer by Targeting Mirna-16-5p/vegfa

MiR-30 Suppresses Lung Cancer Cell 95D Epithelial Mesenchymal Transition and Invasion Through Targeted Regulating Snail.

RETRACTED: Changed Expression of Micrornas May Predict Postoperative Atrial Fibrillation in Patients with Cardiac Surgery (retracted Article. See Vol. 25, Pg. 3400, 2021)

MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway

[Retracted] MicroRNA‑874 Inhibits Growth, Induces Apoptosis and Reverses Chemoresistance in Colorectal Cancer by Targeting X‑linked Inhibitor of Apoptosis Protein

Withdrawn: MicroRNA‐214‐3p Protects Against Myocardial Ischemia–reperfusion Injury by Targeting Demethylase Lysine Demethylase 3A

Retraction Note: Regulation of miRNAs on c-met protein expression in ovarian cancer and its implication

Retraction Note: MicroRNA-199a regulates myocardial fibrosis in rats by targeting SFRP5

RETRACTED: MicroRNA-34 suppresses proliferation of human ovarian cancer cells by triggering autophagy and apoptosis and inhibits cell invasion by targeting Notch 1.

Retraction Notice to “corrigendum to ‘Microrna-134 Prevents the Progression of Esophageal Squamous Cell Carcinoma Via the PLXNA1-mediated MAPK Signalling Pathway’ [ebiomedicine 46 (2019) 66–78]” [ebiomedicine 55 (2020) 102772]

RETRACTED: MicroRNA-375-3p in Endothelial Progenitor Cells-Derived Extracellular Vesicles Relieves Myocardial Injury in Septic Rats Via BRD4-mediated PI3K/AKT Signaling Pathway.

[Retracted] MicroRNA‐329‐3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer

RETRACTED ARTICLE: MicroRNA-183 Affects the Development of Gastric Cancer by Regulating Autophagy Via MALAT1-miR-183-SIRT1 Axis and PI3K/AKT/mTOR Signals

[Retracted] microRNA‐206 overexpression inhibits cellular proliferation and invasion of estrogen receptor α‐positive ovarian cancer cells

WITHDRAWN: MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer.

[Retracted] MicroRNA‐320 targets mitogen‐activated protein kinase 1 to inhibit cell proliferation and invasion in epithelial ovarian cancer

[Retracted] MicroRNA‐425 is downregulated in nasopharyngeal carcinoma and regulates tumor cell viability and invasion by targeting hepatoma‐derived growth factor

[Retracted] Protective effect of microRNA‐381 against inflammatory damage of endothelial cells during coronary heart disease by targeting CXCR4

Retracted: Expression of lncRNA-ANRIL before and after Treatment and Its Predictive Value for Short-Term Survival in Patients with Coronary Heart Disease

Retraction: Novel Approaches for Gene‐specific Interference Via Manipulating Actions of Micrornas: Examination on the Pacemaker Channel Genes HCN2 and HCN4